Empowering Oncology Decisions

DiagnoCure is a life sciences company commercializing high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in making critical treatment decisions.

Special Announcement

New Study: the PCA3 test could be useful to predict the outcome of an initial prostate biopsy

Visit our media room for more information